May 13, 2022
Medavail Holdings Inc., a provider of retail pharmacy kiosks, reported a higher loss against a boost in sales for Q1 2022, according to an earnings report. Highlights include:
Shares traded at $2.23 today against a 52-week range of 79 cents —- $14.59.
"We delivered robust sales growth in the first quarter and achieved a milestone in our pharmacy technology business with the completion of our integration with Epic," CEO Mark Doerr said in the press release. "There is clear momentum and demand for our differentiated pharmacy technology solutions, and we are deliberately investing in our teams and business to drive this growth."